An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

The director of The University of Queensland’s Research Computing Centre has been named the iTnews Education Chief Information Officer of the Year.

IMB is home to some of the world’s most influential scientific minds, measured by Thomson Reuters Highly Cited Researchers index. New group leader Professor Grant Montgomery was named in this prestigious index.

The Community for Open Antimicrobial Drug Discovery (CO-ADD) at The University of Queensland’s Institute for Molecular Bioscience (IMB) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.

Protagonist Therapeutics, a spin-out company from IMB, has begun clinical trials with a novel drug candidate being investigated as a potential 'oral targeted therapy' for inflammatory bowel diseases.

The Australian Research Council has awarded five new Future Fellows at The University of Queensland, including IMB's Dr Sonia Henriques whose research has huge potential in reducing global carbon emissions.